Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance

Abstract Background Multidrug resistant (MDR) Gram-negative bacterial infections are a serious threat to human health due to the lack of effective treatments. In this study, we selected 50 Gram-negative bacterial strains, including 26 strains of Klebsiella pneumoniae and 24 strains of Escherichia co...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Li Liu, Jingyi Yu, Xiaofei Shen, Xingwei Cao, Qing Zhan, Yinjuan Guo, Fangyou Yu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2020-10-01
Saila:	BMC Microbiology
Gaiak:	Polymyxin B Resveratrol Combination therapy Multidrug resistance (MDR)
Sarrera elektronikoa:	http://link.springer.com/article/10.1186/s12866-020-01995-1
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!